Category Archives: Press Releases

FIRALIS S.A. appoints Alain FOURNELLE as Chief Financial Officer

    Huningue, France, July 31st, 2019 - Firalis S.A (“Firalis”), a developer of biomarker-based products and provider of biomarker services announces the appointment of Alain Fournelle as new Chief Financial Officer. Alain has three decades of financial expertise in various fields of financial recovery, due diligence and mergers & acquisitions as consultant at E&Y…
Read more

Amoneta Diagnostics has been awarded up to of USD 2 million by the Alzheimer’s Drug Discovery Foundation (ADDF)

      In support of the MemoryLINC project “Validation of a Rapid Non-Invasive Diagnostic Test to Predict Mild-Cognitive Impairment and Early Alzheimer's Disease”, Amoneta Diagnostics S.A.S. has been awarded up to of USD 2 million by the Alzheimer’s Drug Discovery Foundation (ADDF) Diagnostics Accelerator Huningue, May 31st, 2019 – Amoneta Diagnostics SAS, an affiliate…
Read more

Firalis contribute to the Pacific CONSORTIUM through its proprietary targeted RNA sequencing tools FiMICS and BIOPRED to redefine heart failure with preserved ejection fraction (HFpEF)

  Major health stakeholders in France launch the PACIFIC Consortium to redefine heart failure with preserved ejection fraction (HFpEF) Paris (France) - January 21, 2019 - Sanofi, Servier, Medicen Paris-Region, BpiFrance, the “Secrétariat Général Pour l’Investissement”, “l’Assistance Publique– Hôpitaux de Paris”, Inserm, Bioserenity, Casis, Fealinx and Firalis announced the launch of the PACIFIC consortium (Physiopathology,…
Read more

Amoneta Diagnostics is launching a participative fundraising campaign to launch its first-ever blood diagnostic test for Alzheimer’s disease.

  Amoneta Diagnostics lance une campagne de financement participatif afin de réunir les fonds nécessaires au lancement commercial de son tout premier test IVD ADDIA. Un test de diagnostic sanguin pour la maladie d'Alzheimer.  Please see below French PR. France, Huningue, le 19 Novembre 2018 La maladie d’Alzheimer touche 47 millions de personnes à l’échelle…
Read more